Skip to content

Clinical trials

Papillomavirus Infections trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Papillomavirus Infections Country / region: Australia Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20061
20091
20111
20172
20181
20233
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Unknown status3
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline5
Antiva Biosciences3
Monash University2
National Institute of Hygiene and Epidemiology, Vietnam1
The Alfred1
Wuhan BravoVax Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Papillomavirus Infections13
Anus Neoplasms4
Uterine Cervical Neoplasms3
HIV Infections2
Multiple Endocrine Neoplasia Type 12
Neoplasms2
Squamous Intraepithelial Lesions2
Condylomata Acuminata1
Sexually Transmitted Diseases1

Trials

Showing 51 to 13 of 13. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.